An Overview of Cancer Treatment With CAR-T Cell Therapy

A cutting-edge immunotherapy technique called CAR-T cell Therapy Treatment is intended to cure a variety of malignancies, including blood diseases like leukemia and lymphoma. Through genetic modification, a patient's T cells are better able to identify and combat cancer cells.
CAR-T therapy is usually considered for patients with relapsed or refractory tumors, particularly B-cell cancers such as lymphoma, leukemia, and multiple myeloma, that have not responded to conventional treatments such as radiation or chemotherapy. The initial part of the process is leukapheresis, in which T cells are separated from the patient's blood using apheresis. This procedure typically takes two to four hours.